Correlation Between Tscan Therapeutics and Western Acquisition
Can any of the company-specific risk be diversified away by investing in both Tscan Therapeutics and Western Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tscan Therapeutics and Western Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tscan Therapeutics and Western Acquisition Ventures, you can compare the effects of market volatilities on Tscan Therapeutics and Western Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tscan Therapeutics with a short position of Western Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tscan Therapeutics and Western Acquisition.
Diversification Opportunities for Tscan Therapeutics and Western Acquisition
-0.43 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Tscan and Western is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Tscan Therapeutics and Western Acquisition Ventures in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Western Acquisition and Tscan Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tscan Therapeutics are associated (or correlated) with Western Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Western Acquisition has no effect on the direction of Tscan Therapeutics i.e., Tscan Therapeutics and Western Acquisition go up and down completely randomly.
Pair Corralation between Tscan Therapeutics and Western Acquisition
Given the investment horizon of 90 days Tscan Therapeutics is expected to generate 3.01 times more return on investment than Western Acquisition. However, Tscan Therapeutics is 3.01 times more volatile than Western Acquisition Ventures. It trades about -0.02 of its potential returns per unit of risk. Western Acquisition Ventures is currently generating about -0.13 per unit of risk. If you would invest 508.00 in Tscan Therapeutics on September 4, 2024 and sell it today you would lose (23.00) from holding Tscan Therapeutics or give up 4.53% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 95.24% |
| Values | Daily Returns |
Tscan Therapeutics vs. Western Acquisition Ventures
Performance |
| Timeline |
| Tscan Therapeutics |
| Western Acquisition |
Tscan Therapeutics and Western Acquisition Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tscan Therapeutics and Western Acquisition
The main advantage of trading using opposite Tscan Therapeutics and Western Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tscan Therapeutics position performs unexpectedly, Western Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Western Acquisition will offset losses from the drop in Western Acquisition's long position.| Tscan Therapeutics vs. Candel Therapeutics | Tscan Therapeutics vs. Cingulate Warrants | Tscan Therapeutics vs. Unicycive Therapeutics | Tscan Therapeutics vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |